Andrew Pollard, director of Oxford University's research team, which is co-developing the Corona 19 vaccine with AstraZeneca

Andrew Pollard, director of Oxford University's research team, 강남풀살롱 which is co-developing the Corona 19 vaccine with AstraZeneca, said in an interview with BBC Radio on the 19th (local time) that "the results of a positive three-phase clinical trial will be announced before Christmas." SK Bioscience, a Korean pharmaceutical company that signed a letter of intent (LOI) with AstraZeneca in July, is also drawing attention. 어게인셔츠룸 In July, SK Bioscience signed a three-way cooperation letter (LOI) with AstraZeneca and the Ministry of Health and Welfare for the domestic and global supply of Corona 19 vaccine candidate substance "AZD1222." The LOI includes SK Bioscience's participation in manufacturing the Corona 19 vaccine, while the Ministry of Health and Welfare supports the two companies' cooperation in producing and exporting 퍼펙트가라오케 vaccines to be implemented quickly.